Aqua Bio Technology ASA (OB:ABTEC) completed the acquisition of Ovalen As from Coc Invest AS.
Aqua Bio Technology ASA (OB:ABTEC) completed the acquisition of Ovalen As from Coc Invest AS on April 12, 2024. NOK 6 million of the purchase price will be settled through the issuance of 1,200,000 consideration shares at a subscription price of NOK 5 per Consideration Share. The Acquisition was subject to a successful due diligence which was completed to ABT's satisfaction and ABT's board of directors has approved the transaction which will be completed on the terms initially agreed. Ovalen had operating revenues of NOK 17 million with an EBITA of NOK 1.1 million in 2023.